STOCK TITAN

Standard BioTools (LAB) holders report 7.3% stake in amended ownership filing

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

STANDARD BIOTOOLS INC. received an amended Schedule 13G filing from MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman, reporting a significant ownership position. The reporting persons collectively beneficially own 28,813,904 shares of Common Stock, representing 7.3% of the outstanding class.

This percentage is calculated based on 28,813,904 shares beneficially owned as of June 30, 2026, and 392,578,808 shares outstanding as of August 3, 2026. The reporting persons have 0 shares with sole voting or dispositive power and 28,813,904 shares with shared voting and dispositive power, indicating coordinated control over this stake.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 28,813,904 shares Common Stock beneficially owned as of 06/30/2026 by the reporting persons
Percent of class 7.3% Portion of STANDARD BIOTOOLS INC. Common Stock represented by the reported holdings
Shares outstanding 392,578,808 shares Common Stock outstanding as of August 3, 2026 used for ownership calculation
Shared voting power 28,813,904 shares Number of shares over which the reporting persons share voting power
Sole voting power 0 shares Number of shares over which the reporting persons have sole voting power
Shared dispositive power 28,813,904 shares Number of shares over which the reporting persons share dispositive power
beneficially owned financial
"The calculation is based upon 28,813,904 shares of Common Stock beneficially owned as of 06/30/2026"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 28,813,904.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 28,813,904.00"
percent of class financial
"Percent of class: 7.3%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
Schedule 13G/A regulatory
"This /A is being filed by: i. MAK Capital Fund LP"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

What ownership stake in STANDARD BIOTOOLS INC. (LAB) is reported in this Schedule 13G/A?

The reporting group holds a 7.3% stake in STANDARD BIOTOOLS INC., representing 28,813,904 shares of Common Stock, based on 392,578,808 shares outstanding as of August 3, 2026.

Who are the reporting persons in the STANDARD BIOTOOLS INC. (LAB) Schedule 13G/A?

The filing is submitted by MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman, who are collectively referred to as the reporting persons and share voting and dispositive power over the reported shares.

How many STANDARD BIOTOOLS INC. (LAB) shares have shared voting power?

The reporting persons have shared voting power over 28,813,904 shares of STANDARD BIOTOOLS INC. Common Stock and no sole voting power, reflecting coordinated control over this entire reported position.

What is the share count used to calculate the 7.3% ownership of LAB?

The 7.3% ownership is based on 28,813,904 shares beneficially owned and a total of 392,578,808 shares of Common Stock outstanding as of August 3, 2026, as reported by the issuer.

Does MAK Capital report sole or shared dispositive power over STANDARD BIOTOOLS (LAB) shares?

The reporting persons disclose 0 shares with sole dispositive power and 28,813,904 shares with shared dispositive power, meaning decisions to sell or otherwise dispose are held jointly rather than individually.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





34385P108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The calculation is based upon 28,813,904 shares of Common Stock beneficially owned as of 06/30/2026 and a total of 392,578,808 shares of Common Stock, $0.001 par value per share, outstanding as of August 3, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The calculation is based upon 28,813,904 shares of Common Stock beneficially owned as of 06/30/2026 and a total of 392,578,808 shares of Common Stock, $0.001 par value per share, outstanding as of August 3, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The calculation is based upon 28,813,904 shares of Common Stock beneficially owned as of 06/30/2026 and a total of 392,578,808 shares of Common Stock, $0.001 par value per share, outstanding as of August 3, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 5, 2026.


SCHEDULE 13G



MAK CAPITAL ONE LLC
Signature:/s/ Michael A. Kaufman
Name/Title:Managing Member
Date:08/14/2026
MAK Capital Fund LP
Signature:/s/ Michael A. Kaufman
Name/Title:Managing Member
Date:08/14/2026
Kaufman Michael A
Signature:/s/ Michael A. Kaufman
Name/Title:Michael A. Kaufman
Date:08/14/2026